Symbols / TECX $34.79 +4.66%
TECX Chart
About
Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPCR modulator bispecific for treating fibrosis; and other GPCR modulators. The company is headquartered in Watertown, Massachusetts.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 653.24M |
| Enterprise Value | 400.72M | Income | -74.15M | Sales | — |
| Book/sh | 13.41 | Cash/sh | 13.52 | Dividend Yield | — |
| Payout | 0.00% | Employees | 60 | IPO | — |
| P/E | — | Forward P/E | -7.43 | PEG | — |
| P/S | — | P/B | 2.59 | P/C | — |
| EV/EBITDA | -4.85 | EV/Sales | — | Quick Ratio | 26.26 |
| Current Ratio | 26.62 | Debt/Eq | 0.51 | LT Debt/Eq | — |
| EPS (ttm) | -4.24 | EPS next Y | -4.68 | EPS Growth | — |
| Revenue Growth | — | Earnings | 2026-05-07 | ROA | -25.38% |
| ROE | -37.82% | ROIC | — | Gross Margin | 0.00% |
| Oper. Margin | 0.00% | Profit Margin | 0.00% | Shs Outstand | 18.78M |
| Shs Float | 10.94M | Short Float | 34.37% | Short Ratio | 7.39 |
| Short Interest | — | 52W High | 36.03 | 52W Low | 13.70 |
| Beta | — | Avg Volume | 414.79K | Volume | 415.09K |
| Target Price | $78.25 | Recom | Strong_buy | Prev Close | $33.24 |
| Price | $34.79 | Change | 4.66% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$78.25
Mean price target
2. Current target
$34.79
Latest analyst target
3. DCF / Fair value
$-37.61
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$34.79
Low
$60.00
High
$101.00
Mean
$78.25
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-01-08 | main | Truist Securities | Buy → Buy | $60 |
| 2025-09-03 | init | Oppenheimer | — → Outperform | $80 |
| 2025-07-21 | init | Truist Securities | — → Buy | $64 |
| 2025-06-06 | init | LifeSci Capital | — → Outperform | $87 |
| 2025-05-15 | main | Mizuho | Outperform → Outperform | $85 |
| 2025-04-21 | init | Mizuho | — → Outperform | $51 |
| 2025-03-21 | main | Wells Fargo | Overweight → Overweight | $101 |
| 2025-01-31 | main | Wells Fargo | Overweight → Overweight | $112 |
| 2024-11-20 | init | Raymond James | — → Outperform | $65 |
| 2024-11-12 | main | Wells Fargo | Overweight → Overweight | $79 |
| 2024-11-11 | main | Leerink Partners | Outperform → Outperform | $69 |
| 2024-08-22 | init | Wells Fargo | — → Overweight | $55 |
| 2024-07-24 | init | Leerink Partners | — → Outperform | $49 |
| 2024-06-26 | init | Piper Sandler | — → Overweight | $76 |
| 2024-06-24 | init | TD Cowen | — → Buy | — |
- $TECX stock is up 19% today. Here's what we see in our data. - Quiver Quantitative Fri, 06 Mar 2026 19
- Peter Mcnamara Sells 6,262 Shares of Tectonic Therapeutic (NASDAQ:TECX) Stock - MarketBeat Mon, 09 Mar 2026 22
- (TECX) Trading Signals (TECX:CA) - Stock Traders Daily ue, 10 Mar 2026 15
- TECX - Tectonic Therapeutic Inc Latest Stock News & Market Updates - Stock Titan Sun, 22 Feb 2026 16
- Insider Sell: Marcella Ruddy Sells Shares of Tectonic Therapeuti - GuruFocus ue, 10 Mar 2026 00
- Tectonic Therapeutic (TECX): LifeSci Capital Reiterates Buy Rating - Yahoo Finance Wed, 10 Dec 2025 08
- Tectonic Therapeutic (NASDAQ:TECX) Shares Down 9.8% - Should You Sell? - MarketBeat Mon, 09 Mar 2026 17
- Moderna board veteran François Nader to lead Tectonic Therapeutic - Stock Titan Mon, 23 Feb 2026 08
- Insider Purchase: Chief Executive Officer of $TECX Buys 2,500 Shares - Quiver Quantitative hu, 12 Feb 2026 08
- Insider Selling: Tectonic Therapeutic (NASDAQ:TECX) Insider Sells 10,000 Shares of Stock - MarketBeat Mon, 09 Mar 2026 22
- Tectonic Therapeutic (NASDAQ:TECX) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance Sat, 22 Nov 2025 08
- Insider Selling: Tectonic Therapeutic (NASDAQ:TECX) Insider Sells 1,649 Shares of Stock - MarketBeat Fri, 06 Mar 2026 00
- Tectonic Therapeutic (NASDAQ:TECX) Hits New 12-Month High - Here's Why - MarketBeat hu, 05 Mar 2026 17
- (TECX) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily Sun, 01 Mar 2026 12
- Tectonic Therapeutic (NASDAQ:TECX) Trading Up 11.4% - What's Next? - MarketBeat Wed, 04 Mar 2026 20
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 2715 | 9113 | — | Conversion of Exercise of derivative security at price 2.38 - 14.71 per share. | MCNAMARA PETER | Officer | — | 2026-03-06 00:00:00 | D |
| 1 | 6262 | 188935 | — | Sale at price 30.00 - 35.00 per share. | MCNAMARA PETER | Officer | — | 2026-03-06 00:00:00 | D |
| 2 | 10000 | 300000 | — | Sale at price 30.00 per share. | RUDDY MARCELLA KUHLMAN M.D. | Officer | — | 2026-03-06 00:00:00 | D |
| 3 | 76500 | — | — | Stock Award(Grant) at price 0.00 per share. | REICIN ALISE S | Chief Executive Officer | — | 2026-03-04 00:00:00 | D |
| 4 | 26500 | — | — | Stock Award(Grant) at price 0.00 per share. | LOCHNER DANIEL J. | Chief Financial Officer | — | 2026-03-04 00:00:00 | D |
| 5 | 23000 | — | — | Stock Award(Grant) at price 0.00 per share. | MCNAMARA PETER | Officer | — | 2026-03-04 00:00:00 | D |
| 6 | 19500 | — | — | Stock Award(Grant) at price 0.00 per share. | SCHWABISH MARC PH.D. | Officer | — | 2026-03-04 00:00:00 | D |
| 7 | 26500 | — | — | Stock Award(Grant) at price 0.00 per share. | RUDDY MARCELLA KUHLMAN M.D. | Officer | — | 2026-03-04 00:00:00 | D |
| 8 | 3299 | 77627 | — | Sale at price 22.06 - 25.00 per share. | MCNAMARA PETER | Officer | — | 2026-03-04 00:00:00 | D |
| 9 | 2500 | 52750 | — | Purchase at price 21.10 per share. | REICIN ALISE S | Chief Executive Officer | — | 2026-02-11 00:00:00 | D |
Financials
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.21 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -71.48M | -52.62M | -42.45M | -31.67M |
| TotalUnusualItems | -3.61M | 1.25M | 643.00K | 7.13M |
| TotalUnusualItemsExcludingGoodwill | -3.61M | 1.25M | 643.00K | 7.13M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -74.15M | -57.98M | -42.82M | -32.18M |
| ReconciledDepreciation | 1.38M | 1.65M | 1.48M | 1.01M |
| EBITDA | -71.48M | -56.23M | -41.19M | -31.03M |
| EBIT | -72.86M | -57.88M | -42.67M | -32.04M |
| NetInterestIncome | 11.23M | 4.15M | 429.00K | 5.00K |
| InterestExpense | 63.00K | 107.00K | 152.00K | 144.00K |
| InterestIncome | 11.30M | 4.26M | 581.00K | 149.00K |
| NormalizedIncome | -74.15M | -54.37M | -44.08M | -32.82M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -74.15M | -57.98M | -42.82M | -32.18M |
| TotalExpenses | 84.04M | 58.02M | 44.65M | 32.83M |
| TotalOperatingIncomeAsReported | -84.04M | -58.02M | -44.65M | -32.83M |
| DilutedAverageShares | 8.49M | 14.73M | 14.73M | 14.73M |
| BasicAverageShares | 8.49M | 14.73M | 14.73M | 14.73M |
| DilutedEPS | -6.83 | -2.91 | -2.18 | -0.61 |
| BasicEPS | -6.83 | -2.91 | -2.18 | -0.61 |
| DilutedNIAvailtoComStockholders | -74.15M | -57.98M | -42.82M | -32.18M |
| NetIncomeCommonStockholders | -74.15M | -57.98M | -42.82M | -32.18M |
| NetIncome | -74.15M | -57.98M | -42.82M | -32.18M |
| NetIncomeIncludingNoncontrollingInterests | -74.15M | -57.98M | -42.82M | -32.18M |
| NetIncomeContinuousOperations | -74.15M | -57.98M | -42.82M | -32.18M |
| TaxProvision | 1.23M | 0.00 | ||
| PretaxIncome | -72.92M | -57.98M | -42.82M | -32.18M |
| OtherIncomeExpense | -119.00K | -4.12M | 1.40M | 645.00K |
| OtherNonOperatingIncomeExpenses | -119.00K | -511.00K | 141.00K | 2.00K |
| GainOnSaleOfSecurity | -3.61M | 1.25M | 643.00K | 7.13M |
| NetNonOperatingInterestIncomeExpense | 11.23M | 4.15M | 429.00K | 5.00K |
| InterestExpenseNonOperating | 63.00K | 107.00K | 152.00K | 144.00K |
| InterestIncomeNonOperating | 11.30M | 4.26M | 581.00K | 149.00K |
| OperatingIncome | -84.04M | -58.02M | -44.65M | -32.83M |
| OperatingExpense | 84.04M | 58.02M | 44.65M | 32.83M |
| ResearchAndDevelopment | 63.49M | 41.36M | 36.97M | 25.65M |
| SellingGeneralAndAdministration | 20.55M | 16.65M | 7.68M | 7.18M |
| GeneralAndAdministrativeExpense | 20.55M | 16.65M | 7.68M | 7.18M |
| OtherGandA | 9.00M | 8.79M | 3.74M | 3.24M |
| SalariesAndWages | 11.55M | 7.86M | 3.94M | 3.94M |
| TotalRevenue | 0.00 | 0.00 | 0.00 | 0.00 |
| OperatingRevenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 18.74M | 14.86M | 14.73M | 14.73M |
| ShareIssued | 18.74M | 14.86M | 14.73M | 14.73M |
| TotalDebt | 1.28M | 3.30M | 4.34M | 5.79M |
| TangibleBookValue | 251.33M | 140.78M | -84.64M | -45.65M |
| InvestedCapital | 251.33M | 140.78M | -84.64M | -45.65M |
| WorkingCapital | 247.69M | 135.25M | -10.00M | 29.20M |
| NetTangibleAssets | 251.33M | 140.78M | -84.64M | -45.65M |
| CapitalLeaseObligations | 1.28M | 3.30M | 4.34M | 5.79M |
| CommonStockEquity | 251.33M | 140.78M | -84.64M | -45.65M |
| TotalCapitalization | 251.33M | 140.78M | -84.64M | -45.65M |
| TotalEquityGrossMinorityInterest | 251.33M | 140.78M | -84.64M | -45.65M |
| StockholdersEquity | 251.33M | 140.78M | -84.64M | -45.65M |
| GainsLossesNotAffectingRetainedEarnings | -96.00K | 9.00K | -11.00K | |
| OtherEquityAdjustments | -96.00K | 9.00K | -11.00K | |
| RetainedEarnings | -222.74M | -148.59M | -90.60M | -47.78M |
| AdditionalPaidInCapital | 474.16M | 289.35M | 5.98M | 2.13M |
| CapitalStock | 2.00K | 2.00K | 0.00 | 0.00 |
| CommonStock | 2.00K | 2.00K | 0.00 | 0.00 |
| PreferredStock | 0.00 | 0.00 | 0.00 | |
| TotalLiabilitiesNetMinorityInterest | 9.71M | 12.13M | 124.03M | 92.86M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 43.00K | 519.00K | 83.15M | 85.03M |
| OtherNonCurrentLiabilities | 56.00K | |||
| PreferredSecuritiesOutsideStockEquity | 0.00 | 80.63M | 80.63M | 42.61M |
| NonCurrentDeferredLiabilities | 0.00 | 410.00K | ||
| LongTermDebtAndCapitalLeaseObligation | 43.00K | 519.00K | 2.52M | 4.34M |
| LongTermCapitalLeaseObligation | 43.00K | 519.00K | 2.52M | 4.34M |
| CurrentLiabilities | 9.67M | 11.61M | 40.89M | 7.84M |
| OtherCurrentLiabilities | 30.52M | 499.00K | 643.00K | |
| CurrentDeferredLiabilities | 0.00 | 6.00K | ||
| CurrentDebtAndCapitalLeaseObligation | 1.23M | 2.78M | 1.82M | 1.45M |
| CurrentCapitalLeaseObligation | 1.23M | 2.78M | 1.82M | 1.45M |
| PensionandOtherPostRetirementBenefitPlansCurrent | 4.11M | 3.58M | 2.86M | 2.16M |
| PayablesAndAccruedExpenses | 4.32M | 5.24M | 5.69M | 3.73M |
| CurrentAccruedExpenses | 3.23M | 4.26M | 5.29M | 3.16M |
| Payables | 1.09M | 976.00K | 409.00K | 574.00K |
| AccountsPayable | 1.09M | 976.00K | 409.00K | 574.00K |
| TotalAssets | 261.04M | 152.91M | 39.40M | 47.21M |
| TotalNonCurrentAssets | 3.68M | 6.05M | 8.52M | 10.17M |
| OtherNonCurrentAssets | 1.12M | 743.00K | 618.00K | 613.00K |
| NonCurrentDeferredAssets | 0.00 | 669.00K | ||
| NetPPE | 2.55M | 5.30M | 7.23M | 9.55M |
| AccumulatedDepreciation | -3.41M | -2.75M | -1.86M | -877.00K |
| GrossPPE | 5.96M | 8.05M | 9.08M | 10.43M |
| Leases | 25.00K | 25.00K | 25.00K | 25.00K |
| ConstructionInProgress | 0.00 | 38.00K | 49.00K | 340.00K |
| OtherProperties | 5.66M | 7.74M | 8.62M | 9.96M |
| MachineryFurnitureEquipment | 281.00K | 281.00K | 405.00K | 393.00K |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 257.36M | 146.86M | 30.88M | 37.04M |
| OtherCurrentAssets | 2.97M | 5.62M | 2.12M | 1.08M |
| RestrictedCash | 587.00K | 0.00 | ||
| CashCashEquivalentsAndShortTermInvestments | 253.80M | 141.24M | 28.77M | 35.97M |
| CashAndCashEquivalents | 253.80M | 141.24M | 28.77M | 35.97M |
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -60.29M | -59.24M | -40.96M | -29.73M |
| RepaymentOfDebt | -489.00K | -475.00K | -499.00K | -393.00K |
| IssuanceOfDebt | 0.00 | 4.00M | ||
| IssuanceOfCapitalStock | 173.10M | 94.60M | 34.12M | 38.02M |
| CapitalExpenditure | -208.00K | -156.00K | -279.00K | -2.09M |
| InterestPaidSupplementalData | 63.00K | 107.00K | 152.00K | 144.00K |
| EndCashPosition | 254.87M | 141.83M | 29.36M | 36.55M |
| BeginningCashPosition | 141.83M | 29.36M | 36.55M | 28.65M |
| EffectOfExchangeRateChanges | -95.00K | -8.00K | 16.00K | |
| ChangesInCash | 113.14M | 112.48M | -7.21M | 7.90M |
| FinancingCashFlow | 173.35M | 171.71M | 33.75M | 37.63M |
| CashFlowFromContinuingFinancingActivities | 173.35M | 171.71M | 33.75M | 37.63M |
| NetOtherFinancingCharges | -485.00K | 75.97M | ||
| ProceedsFromStockOptionExercised | 1.23M | 1.62M | 121.00K | 4.00K |
| NetPreferredStockIssuance | 38.02M | 37.81M | ||
| PreferredStockIssuance | 38.02M | 37.81M | ||
| NetCommonStockIssuance | 173.10M | 94.60M | 34.12M | |
| CommonStockIssuance | 173.10M | 94.60M | 34.12M | |
| NetIssuancePaymentsOfDebt | -489.00K | -475.00K | -499.00K | -393.00K |
| NetLongTermDebtIssuance | -489.00K | -475.00K | -499.00K | -393.00K |
| LongTermDebtPayments | -489.00K | -475.00K | -499.00K | -393.00K |
| LongTermDebtIssuance | 0.00 | 4.00M | ||
| InvestingCashFlow | -138.00K | -156.00K | -279.00K | -2.09M |
| CashFlowFromContinuingInvestingActivities | -138.00K | -156.00K | -279.00K | -2.09M |
| NetPPEPurchaseAndSale | -138.00K | -156.00K | -279.00K | -2.09M |
| SaleOfPPE | 70.00K | 0.00 | ||
| PurchaseOfPPE | -208.00K | -156.00K | -279.00K | -2.09M |
| OperatingCashFlow | -60.08M | -59.08M | -40.68M | -27.64M |
| CashFlowFromContinuingOperatingActivities | -60.08M | -59.08M | -40.68M | -27.64M |
| ChangeInWorkingCapital | -70.00K | -10.28M | -584.00K | 1.84M |
| ChangeInOtherCurrentLiabilities | -2.29M | -565.00K | -1.01M | -1.05M |
| ChangeInOtherCurrentAssets | 17.00K | 544.00K | -5.00K | -14.00K |
| ChangeInPayablesAndAccruedExpense | -436.00K | -7.06M | 1.45M | 3.27M |
| ChangeInAccruedExpense | -552.00K | -5.64M | 1.61M | 4.51M |
| ChangeInPayable | 116.00K | -1.42M | -165.00K | -1.23M |
| ChangeInAccountPayable | 116.00K | -1.42M | -165.00K | -1.23M |
| ChangeInPrepaidAssets | 2.64M | -3.19M | -1.02M | -376.00K |
| OtherNonCashItems | 2.12M | 4.04M | -137.00K | 1.23M |
| StockBasedCompensation | 10.50M | 3.49M | 1.12M | 1.12M |
| DepreciationAmortizationDepletion | 1.38M | 1.65M | 1.48M | 1.01M |
| DepreciationAndAmortization | 1.38M | 1.65M | 1.48M | 1.01M |
| OperatingGainsLosses | 153.00K | 264.00K | -643.00K | -7.13M |
| GainLossOnInvestmentSecurities | -643.00K | -7.13M | ||
| GainLossOnSaleOfPPE | 153.00K | 0.00 | 9.00K | |
| GainLossOnSaleOfBusiness | 0.00 | 255.00K | ||
| NetIncomeFromContinuingOperations | -74.15M | -57.98M | -42.82M | -32.18M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for TECX
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|